OncoC4, Inc.
About OncoC4, Inc.
OncoC4 develops first-in-class and best-in-class medicines for hard-to-treat cancers by leveraging CTLA-4, CD24, and siglecs.
Business Information
Target Customers
Industry Categories
Business Model
Funding Timeline
| Round | Date | Amount | Investors |
|---|---|---|---|
| Series B | Oct 03, 2025 | $50.0M | GBA Fund, Hindustan Media Ventures (HMVL), 3E Bioventures Capital +1 more |
Founders
No founder information available.
Investors
3E Bioventures Capital
Venture Capital
GBA Fund
Venture Capital
Hindustan Media Ventures (HMVL)
Corporate
Kaitai
Venture Capital
Recent Mentions
OncoC4, Inc. announced the recent closing of a Series B #financing round of nearly $50 million. The round was led by GBA Fund, and supported by additional capital from the Company's co-founders and existing investors, including HM Capital, 3E Bioventures Capital and Kaitai
New Raise 🏛️ Company: OncoC4 🔗 Website: https://t.co/M7ZWXj3XC6 📊 Amount: $50 Million 🔄 Round: Series B 🧮 Valuation: N/A ⚙️ Industry: Biotechnology
Similar Startups
Tcelltech
86% matchTcelltech is a clinical-stage biopharma focused on developing immunotherapies, particularly a univer...
Immunocore
86% matchImmunocore is a leading biotechnology company focused on developing innovative therapies for cancer ...
Odyssey_Tx
86% matchPrecision immunomodulators for oncology and immunity
Trogenix
85% matchDeveloping curative therapies for aggressive, treatment-resistant cancers.